Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M BARR

Showing results (761-770 of 848) with videos related to

Pageof 85
Sort By:
Frontiers in Public Health|October 26, 2019
Cognitive Impairment in Marginally Housed Youth: Prevalence and Risk FactorsKristina Waclawik, Andrea A Jones, Skye P Barbic, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|November 7, 2022
Postpartum uptake of diabetes screening tests in women with gestational diabetes: The PANDORA studyAnna J Wood, I-Lynn Lee, Elizabeth L M Barr, et al.
BMC Pregnancy and Childbirth|October 30, 2019
Diabetes care in remote Australia: the antenatal, postpartum and inter-pregnancy periodR Kirkham, N Trap-Jensen, J A Boyle, et al.
The Lancet. Oncology|December 17, 2017
Venetoclax for chronic lymphocytic leukaemia progressing after ibrutinib: an interim analysis of a multicentre, open-label, phase 2 trialJeffrey A Jones, Anthony R Mato, William G Wierda, et al.
Neuropsychology|September 20, 2016
Structural brain markers are differentially associated with neurocognitive profiles in socially marginalized people with multimorbid illnessKristina M Gicas, Chantelle J Giesbrecht, William J Panenka, et al.
Haematologica|June 9, 2018
Sustained efficacy and detailed clinical follow-up of first-line ibrutinib treatment in older patients with chronic lymphocytic leukemia: extended phase 3 results from RESONATE-2Paul M Barr, Tadeusz Robak, Carolyn Owen, et al.
Blood Advances|June 15, 2019
Long-term safety of single-agent ibrutinib in patients with chronic lymphocytic leukemia in 3 pivotal studiesSteven E Coutre, John C Byrd, Peter Hillmen, et al.
Diabetes Research and Clinical Practice|October 7, 2019
Birth outcomes in women with gestational diabetes managed by lifestyle modification alone: The PANDORA studyE Cheng, D K Longmore, F Barzi, et al.
Eclinicalmedicine|December 16, 2024
Vitamin D in patients with low tumor-burden indolent non-Hodgkin lymphoma treated with rituximab therapy (ILyAD): a randomized, phase 3 clinical trialJonathan W Friedberg, Michael T Brady, Myla Strawderman, et al.
Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists|November 9, 2018
Volumes of the Hippocampal Formation Differentiate Component Processes of Memory in a Community Sample of Homeless and Marginally Housed PersonsKristina M Gicas, Allen E Thornton, Kristina Waclawik, et al.
Pageof 85

Showing results (761-770 of 848) with videos related to

Sort By:
Pageof 85
Frontiers in Public Health|October 26, 2019
Cognitive Impairment in Marginally Housed Youth: Prevalence and Risk FactorsKristina Waclawik, Andrea A Jones, Skye P Barbic, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|November 7, 2022
Postpartum uptake of diabetes screening tests in women with gestational diabetes: The PANDORA studyAnna J Wood, I-Lynn Lee, Elizabeth L M Barr, et al.
BMC Pregnancy and Childbirth|October 30, 2019
Diabetes care in remote Australia: the antenatal, postpartum and inter-pregnancy periodR Kirkham, N Trap-Jensen, J A Boyle, et al.
The Lancet. Oncology|December 17, 2017
Venetoclax for chronic lymphocytic leukaemia progressing after ibrutinib: an interim analysis of a multicentre, open-label, phase 2 trialJeffrey A Jones, Anthony R Mato, William G Wierda, et al.
Neuropsychology|September 20, 2016
Structural brain markers are differentially associated with neurocognitive profiles in socially marginalized people with multimorbid illnessKristina M Gicas, Chantelle J Giesbrecht, William J Panenka, et al.
Haematologica|June 9, 2018
Sustained efficacy and detailed clinical follow-up of first-line ibrutinib treatment in older patients with chronic lymphocytic leukemia: extended phase 3 results from RESONATE-2Paul M Barr, Tadeusz Robak, Carolyn Owen, et al.
Blood Advances|June 15, 2019
Long-term safety of single-agent ibrutinib in patients with chronic lymphocytic leukemia in 3 pivotal studiesSteven E Coutre, John C Byrd, Peter Hillmen, et al.
Diabetes Research and Clinical Practice|October 7, 2019
Birth outcomes in women with gestational diabetes managed by lifestyle modification alone: The PANDORA studyE Cheng, D K Longmore, F Barzi, et al.
Eclinicalmedicine|December 16, 2024
Vitamin D in patients with low tumor-burden indolent non-Hodgkin lymphoma treated with rituximab therapy (ILyAD): a randomized, phase 3 clinical trialJonathan W Friedberg, Michael T Brady, Myla Strawderman, et al.
Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists|November 9, 2018
Volumes of the Hippocampal Formation Differentiate Component Processes of Memory in a Community Sample of Homeless and Marginally Housed PersonsKristina M Gicas, Allen E Thornton, Kristina Waclawik, et al.
Pageof 85